Background: Although combination therapy with bronchodilators is recommended for chronic obstructive pulmonary disease (COPD), there is insuffi cient evidence for the effi cacy of some combinations of long-acting bronchodilators. Objective: We investigated the effects of a combination therapy with tiotropium and theophylline in COPD patients. Methods: In a 12-week, open-labeled, parallel-group randomized study, pulmonary functions and dyspnea scores were compared between the combination and theophylline alone therapy at baseline, and 4 and 8 weeks after randomization in COPD. Results: Sixty-one COPD patients completed the trial (31 combination therapy, 30 theophylline alone; mean age 70 years; 58 males; mean dyspnea score 2.0 and forced expiratory volume in one second (FEV 1 ) 1.5 L [62.5% predicted]). FEV 1 in the combination group, but not in the theophylline alone, was signifi cantly increased at 4 (1.56 ± 0.13 L, p Ͻ 0.001) and 8 weeks (1.60 ± 0.13 L, p Ͻ 0.001) from the baseline (1.40 ± 0.12 L). In the combination group, but not the theophylline alone group, the dyspnea score was signifi cantly improved after 4 (p Ͻ 0.01) and 8 weeks (p < 0.05) compared with baseline. In 17 patients who did not receive theophylline at screening, treatment with 4 or 8 weeks of theophylline alone did not improve dyspnea score or FEV 1 . Conclusion: Addition of tiotropium therapy to theophylline treatment can improve dyspnea and pulmonary function in COPD. Although this study did not assess whether there was any benefi t of adding theophylline to patients treated with tiotropium, tiotropium can be a useful addition in COPD already treated with theophylline.